Table 3.
Postoperative patient characteristics.
| Total (n = 14) | CABG (n = 10) | Aortic Valve Surgery (n = 2) | CABG and Valvular Surgery (n = 2) | |
|---|---|---|---|---|
| Mechanical ventilation in the ICU (days) | 1.75 (0.9–2.7) | 2.5 (0.8–2.7) | 1.71 (1.69–1.73) | 2.1 (1.7–2.5) |
| Acute renal failure | 4 (28.6%) | 3 (30%) | 0 (0%) | 1 (50%) |
| Duration of renal replacement therapy (days) | 0 (0–1.5) | 0 (0–1.5) | 0 (0–0) | 1 (0.5–1.5) |
| ICU stay (days) | 11.3 ± 1.6 | 11.6 ± 1.8 | 12 ± 7 | 9 ± 6 |
| Hospital stay (days) | 19.5 ± 2 | 20.3 ± 1.9 | 16.5 ± 3.5 | 18.5 ± 13.5 |
| 30-day survival rate | 13 (92.85%) | 10 (100%) | 2 (100%) | 1 (50%) |
| Pneumonia | 3 (21.4%) | 2 (20%) | 0 (0%) | 1 (50%) |
| Time to lactate normalization (h) | 15.4 ± 2.8 | 16.3 ± 3.5 | 16.1 ± 2.1 | 4.8 ± 0 |
| Time to inotrope/vasopressor independence (days) | 2 (0.97–7.25) | 2 (0.6–5.8) | 1.7 (1.7–1.7) | 11.7 (11.7–11.7) |
| Most recent LVEF (%) | 29.1 ± 2.6 | 32.7 ± 1.6 | 28 ± 3 | 12 ± 12 |
| Lactate (24 h postoperatively highest) (mmol/l) | 3.8 ± 0.6 | 3.2 ± 0.4 | 4.3 ± 1.2 | 6.5 ± 3.7 |
| Transfusion of erythrocyte concentrates | 11.5 (8–16.8) | 11.5 (8.5–16) | 11.5 (7.8–15.3) | 15.5 (11.8–19.3) |
| Transfusion of fresh frozen plasma | 4.5 (4–13.3) | 4.5 (4–11) | 13.5 (8.8–18.3) | 13 (8.5–17.5) |
| Transfusion of thrombocyte concentrates | 2.8 ± 0.6 | 2.8 ± 0.9 | 2.5 ± 0.5 | 3 ± 1 |
| Postoperative bleeding (<24 h) | 1 (7.15%) | 1 (10%) | 0 (0%) | 0 (0%) |
Categorical variables are expressed as n (%), and continuous variables are expressed as mean ± standard error of the mean and median with interquartile range.